Is Adlyxin FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Adlyxin is FDA approved and how it is commonly categorized.
Overview
Adlyxin is the brand name for lixisenatide, a GLP-1 receptor agonist used in the treatment of type 2 diabetes. It is prescribed as an injectable medication for blood sugar management.
FDA Status Details
Adlyxin is classified as FDA Approved. It is approved by the FDA as a prescription medication for improving glycemic control in adults with type 2 diabetes.
Approved Use
Adlyxin is approved for use alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is not approved for weight loss treatment.
Brand & Prescription Status
Adlyxin is an FDA-approved branded prescription medication. It should be distinguished from compounded GLP-1 products or non-approved peptide products marketed online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.